Sierra Oncology Inc.

NASDAQ: SRRA · Real-Time Price · USD
54.99
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Sierra Oncology Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
n/a
Cost of Revenue
n/a
Gross Profit
n/a
Operating Income
-94.66M
Interest Income
n/a
Pretax Income
-94.66M
Net Income
-94.66M
Selling & General & Admin
27.43M
Research & Development
67.15M
Other Expenses
n/a
Operating Expenses
94.58M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
94.58M
Income Tax Expense
-3K
Shares Outstanding (Basic)
13.25M
Shares Outstanding (Diluted)
13.25M
EPS (Basic)
-7.14
EPS (Diluted)
-7.14
EBITDA
-94.36M
EBIT
-94.66M
Depreciation & Amortization
305K